SVP Healthcare, Simon Beaulah is speaking at the AI Driven Drug Discovery Summit in Boston, MA.
In a special session Clement Chatelain, Head of Human Genetics at Sanofi will first present AI for Systematic Drug Repositioning followed by PrecisionLife's presentation on Enabling a New Era of Precision Drug Discovery and Repositioning.
Themes that the PrecisionLife talk will cover, include:
- Utilizing AI-driven combinatorial analytics to achieve mechanism-based patient stratification in complex chronic diseases that informs, accelerates and derisks every stage of biopharma innovation
- Harnessing a novel precision medicine approach to systematically identify drug repositioning and out-licensing opportunities at scale
- Generating patient stratification biomarkers to map the right patients to the right targets, right repositioned drugs and drug candidates, right clinical trials, and right treatments
To register for the AI Driven Drug Discovery Summit, visit the event website.